GAMMAPLEX

Quốc gia: Israel

Ngôn ngữ: Tiếng Anh

Nguồn: Ministry of Health

Buy It Now

Thành phần hoạt chất:

IMMUNOGLOBULINS, NORMAL HUMAN

Sẵn có từ:

KAMADA LTD, ISRAEL

Mã ATC:

J06BA02

Dạng dược phẩm:

SOLUTION FOR INFUSION

Thành phần:

IMMUNOGLOBULINS, NORMAL HUMAN 5 G / 100 ML

Tuyến hành chính:

I.V

Loại thuốc theo toa:

Required

Sản xuất bởi:

BIO PRODUCTS LABORATORY LIMITED (BPL), UK

Nhóm trị liệu:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Khu trị liệu:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Chỉ dẫn điều trị:

Replacement therapy in adults, and children and adolescents in:- Primary immunodeficiency syndromes with impaired antibody production - Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed- Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation- Congenital AIDS with recurrent bacterial infectionsImmunomodulation in adults, and children and adolescents in:- Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count- Guillain Barré syndrome- Kawasaki disease

Ngày ủy quyền:

2016-01-31

Tờ rơi thông tin

                                HEAD OFFICE 2 Holzman St., Science Park, P.O. Box 4081, Rehovot,
7670402, Israel | Tel. +972-8-9406472 | Fax. +972-89406473 PLANT Kibbutz Beit Kama, M.P Negev 8532500, Israel | Tel.
+972-8-9913111 | Fax. +972-8-9912083
טסוגוא
8
201
,ה/דבכנ ת/חקור ,ה/אפור
:רישכתה רובע ,ןלהל טרופמכ עדימ ןוכדיע
לע עידוהל תשקבמ עדהמק תרבח
GAMMAPLEX ;
סקלפאמג
SOLUTION FOR INFUSION, I.V.
ןוישירל םאתהב םיליעפ םיביכרמ
:
IMMUNOGLOBULIN NORMAL HUMAN 5g/100 ml
:היוותה
REPLACEMENT THERAPY IN ADULTS, AND CHILDREN AND ADOLESCENTS IN:
-
Primary immunodeficiency syndromes with impaired antibody production
(see section
4.4)
-
Hypogammaglobulinaemia and recurrent bacterial infections in patients
with chronic
lymphocytic leukaemia, in whom prophylactic antibiotics have failed
-
Hypogammaglobulinaemia and recurrent bacterial infections in plateau
phase multiple
myeloma patients who have failed to respond to pneumococcal
immunisation
-
Congenital AIDS with recurrent bacterial infections
IMMUNOMODULATION IN ADULTS, AND CHILDREN AND ADOLESCENTS IN:
-
Primary immune thrombocytopenia (ITP), in patients at high risk of
bleeding or prior to
surgery to correct the platelet count
-
Guillain Barré syndrome
-
Kawasaki disease
יונישה תוהמ
םי
:
סב אפורל ןולעה ןוכדיע ףיע
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
4.4
:)בוהצב תשגדומ הרמחה(
Transfusion related acute lung injuries (TRALI)
There have been reports of TRALI i.e. noncardiogenic pulmonary oedema,
in patients
administered IVIg products.
:תואירבה דרשמ רתאבש תופורתה רגאמב
םוסרפל חלשנ ןכדועמה אפורל ןולעה
HTTPS://WWW.OLD.HEALTH.GOV.IL/UNITS/PHARMACY/TRUFOT/INDEX.ASP , לעבל הינפ י"ע ספדומ ולבקל ןתינו
המק תרבח ,םושירה 'לט( מ"עב עד
08-9406472
.)
,הכרבב
,לדונ הנינפ
הנוממ תחקור
                                
                                Đọc toàn bộ tài liệu
                                
                            

Đặc tính sản phẩm

                                _ _
_ _
_Page 1 of 15 _
GAMMAPLEX
®
SOLUTION FOR INFUSION
1.
NAME OF THE MEDICINAL PRODUCT
Gammaplex
®
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Gammaplex 5 % w/v, solution for infusion.
Human normal immunoglobulin (IVIg)
One ml contains: Human normal immunoglobulin 50 mg (purity of at least
95% IgG).
Each 2.5 g vial of 50 ml contains: 2.5 g of human normal
immunoglobulin.
Each 5 g vial of 100 ml contains: 5 g of human normal immunoglobulin.
Each 10 g vial of 200 ml contains: 10 g of human normal
immunoglobulin.
Distribution of the IgG subclasses (approximate values):
IgG1
62 %
IgG2
31 %
IgG3
6 %
IgG4
1 %
The maximum IgA content is 10 micrograms
/
ml.
Produced from the plasma of human donors.
For the full list of excipients, see section 6.1.
_ _
3.
PHARMACEUTICAL FORM
Gammaplex is a colourless sterile solution for intravenous infusion.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
REPLACEMENT THERAPY IN ADULTS, AND CHILDREN AND ADOLESCENTS IN:
-
Primary immunodeficiency syndromes with impaired antibody production
(see section 4.4)
-
Hypogammaglobulinaemia and recurrent bacterial infections in patients
with
chronic
lymphocytic
leukaemia,
in
whom
prophylactic
antibiotics
have
failed
-
Hypogammaglobulinaemia
and
recurrent
bacterial
infections
in
plateau
phase
multiple
myeloma
patients
who
have
failed
to
respond
to
pneumococcal immunisation
-
Congenital AIDS with recurrent bacterial infections
_ _
_ _
_Page 2 of 15 _
IMMUNOMODULATION IN ADULTS, AND CHILDREN AND ADOLESCENTS IN:
-
Primary
immune
thrombocytopenia
(ITP),
in
patients
at
high
risk
of
bleeding or prior to surgery to correct the platelet count
-
Guillain Barré syndrome
-
Kawasaki disease
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Replacement therapy should be initiated and monitored under the
supervision
of a physician experienced in the treatment of immunodeficiency.
Treatment
at home should be similarly supervised, with the patient fully
assessed and
trained in hospital prior to self-infusion at home.
Posology
The dose and dose regimen is depende
                                
                                Đọc toàn bộ tài liệu
                                
                            

Tìm kiếm thông báo liên quan đến sản phẩm này

Xem lịch sử tài liệu